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Abstract
Objective: To control nosocomial transmission of methicillin-resistant Staphylococcus aureus (MRSA) in resource-limited
healthcare setting with high endemicity.
Methods: Three phases of infection control interventions were implemented in a University-affiliated hospital between 1-
January-2004 and 31-December-2012. The first phase of baseline period, defined as the first 48-months of the study period,
when all MRSA patients were managed with standard precautions, followed by a second phase of 24-months, when a
hospital-wide hand hygiene campaign was launched. In the third phase of 36-months, contact precautions in open cubicle,
use of dedicated medical items, and 2% chlorhexidine gluconate daily bathing for MRSA-positive patients were
implemented while hand hygiene campaign was continued. The changes in the incidence rates of hospital-acquired MRSA-
per-1000-patient admissions, per-1000-patient-days, and per-1000-MRSA-positive-days were analyzed using segmented
Poisson regression (an interrupted time series model). Usage density of broad-spectrum antibiotics was monitored.
Results: During the study period, 4256 MRSA-positive patients were newly diagnosed, of which 1589 (37.3%) were hospital-
acquired. The reduction of hospital-acquired MRSA per 1000-patient admissions, per 1000-patient-days, and per 1000-
MRSA-positive-days from phase 1 to 2 was 36.3% (p,0.001), 30.4% (p,0.001), and 19.6% (p= 0.040), while the reduction of
hospital-acquired MRSA per 1000-patient admissions, per 1000-patient-days, and per 1000-MRSA-positive-days from phase
2 to 3 was 27.4% (p,0.001), 24.1% (p,0.001), and 21.9% (p= 0.041) respectively. This reduction is sustained despite that the
usage density of broad-spectrum antibiotics has increased from 132.02 (phase 1) to 168.99 per 1000 patient-days (phase 3).
Conclusions: Nosocomial transmission of MRSA can be reduced with hand hygiene campaign, contact precautions in open
cubicle, and 2% chlorhexidine gluconate daily bathing for MRSA-positive despite an increasing consumption of broad-
spectrum antibiotics.
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Introduction
The control of nosocomial transmission of methicillin-resistant
Staphylococcus aureus (MRSA) in endemic areas of Asia, Europe, and
North America [1,2,3,4] has demonstrated various degree of
success with the implementation of active surveillance culture,
isolation of MRSA-colonized patients, hand hygiene practice,
environmental cleanliness, targeted or universal decolonization,
and antimicrobial stewardship program. Remarkably, a decreasing
trend in MRSA bacteremia has been seen since 2006 in UK,
following a government initiative to establish a mandatory
surveillance and a target to reduce MRSA bacteremia rates over
a 3-year period [5], facilitated by the corresponding optimization
of administrative support, infrastructural change and resource
allocation [1].
However, the control of MRSA in highly endemic healthcare
setting is more challenging where resources are limited and
isolation facilities are scarce. In Hong Kong, existing hospital
buildings have outdated designs with limited number of isolation
rooms. Hence, patients colonized or infected with vancomycin-
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resistant Enterococci and carbapenem-resistant Enterobacteriaceae,
agents not yet endemic in our healthcare setting, are prioritized
to be isolated in these rooms [6,7]. Meanwhile, our hospital-wide
MRSA control program has to depend on the use of hand hygiene
campaign [8], which has been associated with reduction of MRSA
transmission [9], and contact precautions without single room
isolation facility.
Materials and Methods
A retrospective study was conducted to determine the nosoco-
mial transmission of MRSA in Queen Mary Hospital, a 1600-bed
tertiary referral university-affiliated teaching hospital, between 1
January 2004 and 31 December 2012. Our study period was
divided into three phases: (i) phase 1– baseline observation period
from 1 January 2004 to 31 December 2007; (ii) phase 2– launch of
the first intervention (hospital-wide hand hygiene campaign using
alcohol-based hand rub) from 1 January 2008 to 31 December
2009), and (iii) phase 3– launch of the second intervention
(stepwise implementation of contact precautions in open cubicle
with use of dedicated medical items including blood pressure cuff,
stethoscope, oximeter, tourniquet, and thermometer, and 2%
chlorhexidine gluconate daily bath till discharge for MRSA-
positive patients) from 1 January 2010 to 31 December 2012.
Before the launch of hand hygiene practice campaign in phase 2
and 3, baseline hand hygiene data was collected in 2007. Hand
hygiene audit was continued throughout phase 2 and 3. Briefly,
our infection control nurses performed hand hygiene audit in each
ward at least once a month, monitoring at least 200 hand hygiene
opportunities in each ward per year. Among 200 hand hygiene
opportunities, 130 were of nurses, 40 of medical doctors, 20 of
healthcare assistants, and 10 of allied health professional. Active
surveillance of MRSA was not routinely performed due to limited
resources. Clinical specimens were collected for microbiological
investigation when clinically indicated. MRSA was identified
according to our previous laboratory protocol [10,11]. This study
was approved by the Institutional Review Board at Queen Mary
Hospital. Written informed consent was not obtained because the
present study was a retrospective analysis of a hospital infection
control program. Patient records and information were anon-
ymized and de-identified prior to analysis.
Table 1. The epidemiological characteristics of MRSA in 3 different phases of intervention.
Phase 1 (1 Jan 2004
to 31 Dec 2007)
Phase 2 (1 Jan 2008
to 31 Dec 2009)
Phase 3 (1 Jan 2010
to 31 Dec 2012)
Total number of MRSA 1990 877 1389
Total number of hospital-acquired MRSA 890 315 384
Mean number of hospital-acquired MRSA per month 18.5 13.1 10.7
Total number of community-acquired MRSA 1,100 562 1,005
Mean number of community-acquired MRSA per month 22.9 23.4 27.9
Number of MRSA in the major clinical specialties
Medical unit (hospital- vs community-acquired) 242 vs 481 78 vs 325 108 vs 497
Surgical unit (hospital- vs community-acquired) 327 vs 215 114 vs 85 146 vs 189
Orthopedic unit (hospital- vs community-acquired) 91 vs 193 42 vs 70 55 vs 173
Distribution of MRSA in the major specimen types
Wound specimens (hospital- vs community-acquired)a 206 vs 383 86 vs 209 104 vs 392
Respiratory specimens (hospital- vs
community-acquired)b
361 vs 241 125 vs 133 188 vs 254
Urine specimens (hospital- vs community-acquired)c 82 vs 166 32 vs 74 18 vs 97
Sterile body fluid (hospital- vs community-acquired)d 38 vs 78 25 vs 57 22 vs 145
Blood culture (hospital- vs community-acquired) 56 vs 91 25 vs 40 21 vs 47
Total number of admissions 414,726 230,474 387,136
Mean number of admissions per month 8,640 9,603 10,754
Total number of patient-days 1,586,799 807,159 1,295,828
Mean number of patient-days per month 33,058 33,632 35,995
Total number of MRSA-positive-days 48,297 16,901 30,550
Incidence densities of MRSA
Hospital-acquired MRSA per 1000 admissions 2.146 1.367 0.992
Hospital-acquired MRSA per 1000 patient-days 0.561 0.390 0.296
Hospital-acquired MRSA per 1000 MRSA-positive-days 18.428 18.638 12.570
Community-acquired MRSA per 1000 admissions 2.652 2.438 2.596
Note. Phase 1: baseline observation period; phase 2: launch of the first intervention - hand hygiene campaign; phase 3: continuation of phase 2 plus launch of the
second intervention - contact precautions.
awound specimens included deep wound, superficial wound, and ulcer swabs.
brespiratory specimens included sputum, tracheal aspirates, bronchoalveolar lavage;
curine specimens included mid-stream urine, catheterized urine, suprapubic catheterization, nephrostomy drain urine;
dsterile body fluid included pus.
doi:10.1371/journal.pone.0100493.t001
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Figure 1. Incidence rate of hospital-acquired MRSA per 1000 admissions in the three phases of intervention.
doi:10.1371/journal.pone.0100493.g001
Figure 2. Incidence rate of hospital-acquired MRSA per 1000 patient-days in the three phases of intervention.
doi:10.1371/journal.pone.0100493.g002
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Epidemiology of MRSA
The collection method of epidemiological information of
patients with laboratory culture of MRSA remained unchanged
during the entire study period. Briefly, the patient admission
number and total patient-days were obtained from the computer
system of the hospital record office. The data of clinical isolation of
MRSA was obtained from the laboratory information system. New
cases of hospital-acquired and community-acquired MRSA were
defined as the first isolate of MRSA identified after 48 hours and
within 48 hours of hospitalization, respectively, without preceding
culture positive of MRSA in the past 12 months. Incidence of
hospital-acquired MRSA per 1000 patient admissions, per 1000
patient-days, and per 1000 MRSA-positive-days were defined by
dividing the number of new cases of hospital-acquired MRSA by
the numbers of patient admissions, patient-days, and MRSA-
positive-days respectively, in the period concerned. Incidence
density of community-acquired MRSA per 1000 patient admis-
sions was calculated in similar manner for comparison. The
number of MRSA-positive-days was defined as the number of the
total MRSA patient-days in the hospital, measuring from the time
interval between collection of clinical culture and patient
discharge, in patients with community-acquired and hospital-
acquired MRSA.
Infection Control Program for MRSA
New cases of MRSA were identified by the infection control
team via communication with the microbiology laboratory as
described previously [12]. Except for the intensive care units
[11,13], all patients with MRSA colonization or infection were
managed with standard precautions and cohort nursing in open
cubicle in the baseline period due to limited number of isolation
rooms (phase 1). During phase 2 and 3, hospital-wide hand
hygiene practice using alcohol-based hand rub was promoted. In
phase 3, contact precautions were also enforced in the manage-
ment of MRSA-positive in open cubicles with the provision of
dedicated medical items. In addition, daily bathing with 2%
chlorhexidine gluconate was provided for all MRSA-positive
patients in the later stage in phase 3. Decolonization therapy with
intra-nasal mupirocin was given to high risk patients undergoing
major surgical interventions such as liver transplantation and
cardiac surgery. Outbreak investigation for MRSA was performed
when the number of hospital-acquired MRSA cases exceeded 2
standard deviations (SD) of the mean value over the past 12
months in a particular ward. The environmental cleaning protocol
remained unchanged throughout the study period, and compli-
ance of hand hygiene was audited regularly [14]. The consump-
tion trend of broad-spectrum antibiotics, expressed as defined
daily dose per 1000 patient-days, were obtained from the hospital
information system [15].
Statistical Analysis
Overall patterns of changes in the incidence density of hospital-
acquired MRSA (per 1000 patient admissions, per 1000 patient-
days, and per 1000 MRSA-positive-days), with respect to the
implementation of the infection control interventions, were
analyzed using segmented Poisson regression. This model, also
known as the interrupted time series model, had been widely used
to evaluate interventions related to MRSA incidences [13,16,17].
Pattern of changes in the incidence density of community-acquired
MRSA per 1000 patient admissions was also examined using
segmented Poisson regression for comparison. The full model
under investigation was:
Figure 3. Incidence rate of hospital-acquired MRSA per 1000 MRSA-positive-days in three different phases of intervention.
doi:10.1371/journal.pone.0100493.g003
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ln (l) = b0+ b1(I1)+b2(I2)+b3(T)+b4(T1)+b5(T2), where l denotes
monthly incidence rate, I1 denotes hand hygiene practice
intervention status (before implementation= 0; after implementa-
tion= 1), I2 denotes contact precautions intervention status (before
implementation= 0; after implementation= 1), T denotes time in
months, T1 denotes months since implementation of hygiene
practice (before implementation= 0), and T2 denotes months since
implementation of contact precautions (before implementa-
tion= 0). Significant factors were selected by stepwise selection
procedure. A significance level of 0.05 was adopted. Computation
was performed using R Version 3.0.2.
Results
Epidemiology of MRSA
A total of 4256 MRSA-positive patients were newly identified
during our study period: 2416 (57%) male and 1840 (43%) female,
with a median age of 76 years (ranged 1–111 years), resulting in
95,748 MRSA-positive-days. 1731 (40.7%) of 4256 MRSA-posi-
tive patients were identified during their hospitalization in the
medical unit, while 1076 (25.3%) and 624 (14.7%) were identified
in the surgical and orthopedic unit respectively. The remaining
825 (19.3%) MRSA-positive patients were identified in other
clinical specialties. Evaluation of the first MRSA-positive clinical
specimen received per patient included wound swabs (deep
wound, superficial wound, and ulcer), constituted 1380 (32.4%)
of 4256 specimens, followed by 1302 (30.6%) respiratory
specimens (sputum, tracheal aspirates, bronchoalveolar lavage),
469 (11.0%) urinary specimens (mid-stream urine, catheterized
urine, suprapubic catheterization, nephrostomy drain), 365 (8.6%)
sterile body fluid or pus, and 280 (6.6%) blood cultures. The
epidemiological characteristics of MRSA-positive patients in the 3
phases of intervention were illustrated in Table 1.
The incidence rates of hospital-acquired MRSA per 1000
admissions and 1000 patient-days decreased significantly from
phase 1 to 2 (p,0.001) and from phase 2 to 3 (p,0.001),
equivalent to a cumulative reduction of about 50%; while there
was insignificant trend within each phase. The incidence rate of
hospital-acquired MRSA per 1000 MRSA-positive-days also
reduced significantly from phase 1 to 2 (p = 0.040), and from
phase 2 to 3 (p= 0.041); moreover, there was a significant
increasing trend within phases 1 and 2 (p = 0.007), but a
decreasing trend was noted within phase 3 (p= 0.001) (Table 2,
Figures 1–3). On the other hand, the incidences rate of
community-acquired MRSA per 1000 admissions remained
unchanged throughout the study period.
Infection Control Program for MRSA
All patients with MRSA cultured from clinical specimens were
assessed by the infection control team at bedside. Except for the
275 (6.5%) of 4256 MRSA-positive patients managed in the adult
intensive care unit after July 2004 where isolation room was
available after renovation [13], all other patients with MRSA
colonization or infection were managed by standard precautions in
the baseline period (phase 1). Hand hygiene using alcohol-based
hand rub was actively promoted since 2008 (phase 2), during
which hospital-wide hand hygiene compliance had increased from
23.2% (baseline in 2007), to 57.8% (2008), 67.5% (2009), 66.4%
(2010), 76.3% (2011), and 78.6% (2012). In phase 3, contact
precautions were implemented where a set of dedicated medical
equipment were given to MRSA-positive patients who were
otherwise nursed in open cubicles. In addition, MRSA-positive
patients were bathed daily with 2% chlorhexidine gluconate.
Throughout the study period, decolonization therapy with intra-
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nasal mupirocin was used in 88 (2.1%) specially selected MRSA-
positive patients, out of a total of 4256, from 5 different clinical
specialties. Incidence of nosocomial transmission of MRSA did not
exceed 2 SD of the mean value in any of these wards. Thus no
outbreak investigation was conducted during the study period.
Environmental cleaning of clinical areas, especially frequently
touched communal areas, such as bed rails and bed tables, were
disinfected with 1000 ppm sodium hypochlorite at least once daily
in all general wards. The usage density of broad-spectrum
antibiotics with potential for selecting multiple-drug-resistant
organisms, including cefepime, ceftazidime, cefotaxime, ceftria-
xone, piperacillin, piperacillin/tazobactam, ticarcillin/clavulanate,
cefoperazone/sulbactam, meropenem, imipenem/cilastatin, van-
comycin, linezolid (iv/po), ciprofloxacin (iv/po), levofloxacin (iv/
po), moxifloxacin (iv/po), ofloxacin (iv/po), in the clinical
specialties of intensive care and high dependency unit, medicine,
surgery, orthopedic, and oncology has increased steadily from
132.02 (phase 1), and 144.95 (phase 2), to 168.99 per 1,000
patient-days (phase 3).
Discussion
The nosocomial transmission of MRSA in our hospital has been
successfully reduced by half in terms of 1000-patient admission
and 1000-patient-day during the study period. We have demon-
strated that even without the use of isolation room in resource
limited settings, nosocomial transmission of MRSA can be
minimized by the promotion of hand hygiene using alcohol-based
hand rub, implementation of contact precautions using dedicated
medical equipment and use of 2% chlorhexidine gluconate for
daily bathing when MRSA-positive patients were nursed in open
cubicles. Contact precautions and isolation has been advocated for
patients colonized or infected with MRSA, as recommended by
Health Care Infection Control Practices Advisory Committee, US
[18,19]. However, isolation may be associated with less direct
healthcare worker-patient contact time with which may potentially
result in adverse outcomes [20,21], especially for the critically ill
patients. In fact, isolation of patients did not reduce nosocomial
MRSA transmission in intensive care unit as illustrated in a
prospective two-centre study [22], even though the unfavorable
outcome of this study may be attributed to low compliance of hand
hygiene. The role of patient isolation in the control of nosocomial
MRSA transmission remains controversial [23,24].
In our present study, implementation of hand hygiene campaign
with an overall compliance of over 60% in phase 2 achieved a
significant immediate reduction of incidence rate of hospital-
acquired MRSA per 1000-admission, 1000 patient-days and
1000 MRSA-positive-days. Compellingly, the trend of hospital-
acquired MRSA per 1000 MRSA-positive-days did not decrease
until the introduction of contact precautions with dedicated
medical equipment and the use of 2% chlorhexidine gluconate
daily bathing in phase 3. This observation suggested that use of
hand hygiene alone may not be sufficient in the control of MRSA
nosocomial transmission in patients nursed in open cubicles.
Multifaceted or bundle approach was always adopted to control
MRSA in hospitals [1,25]. Although it is difficult to delineate the
relative contribution of each component, it is important to identify
the critical control points, which are the minimally required
measures in resource limited settings. In phase 3, we have
demonstrated that the use of contact precautions with dedicated
medical equipment, along with 2% chlorhexidine gluconate daily
bathing and hand hygiene practice further reduced hospital-
acquired MRSA in our endemic setting. In fact, use of
chlorhexidine gluconate daily bathing has been associated with a
reduction of hospital-acquired infections, including MRSA, in
previous studies [26,27].
Antibiotic exposure was shown to be associated with MRSA
acquisition [28]. During this study, despite the increasing trend in
broad-spectrum antibiotics consumption, which was predictable in
view of the importation of multiple-drug resistant organisms in our
community [29,30,31], appropriate infection control measures as
described had seemingly overcome the antibiotic selective pressure
in the control of MRSA nosocomial transmission [1,13]. However,
the consumption of antibiotics with activity against MRSA such as
vancomycin and linezolid were also increased from phase 1 to 3.
We postulated that this was related to the frontline clinician’s
choice of empirical antibiotic treatment. As there was a high
incidence of MRSA in phase 1, the clinicians might have adopted
the use of these antibiotics as their empirical treatment regimen
since phase 1 which extended into phases 2 and 3. As there might
be a lag time period before they would revert their empirical
treatment regimen back to agents without activity against MRSA
until they noticed a steady decrease in the prevelance of MRSA
subsequently, the consumption of vancomycin and linezolid
continued to rise in phases 2 and 3. Further long-term follow-up
studies should be conducted to assess this hypothesis.
There are several limitations in this study. Firstly, we did not
perform universal admission screening for MRSA prospectively
due to resource constraint, hence, the true incidences of
community-acquired and hospital-acquired MRSA could not be
determined. Our data presented might represent an underestima-
tion in the incidence of community-acquired MRSA and an
overestimation in the incidence of hospital-acquired MRSA.
However, this potential overestimation in the incidence of
hospital-acquired MRSA has remained constant throughout the
study period and would, therefore, be unlikely to have affected the
extent of the reduction in incidence after the implementation of
our infection control measures. Secondly, we introduced 2%
chlorhexidine gluconate daily bathing in the later stage of phase 3
so that the relative contribution of each component in phase 3
could not be clearly illustrated. However, we believe that our
infection control program can serve as an example for resource
limited settings where active surveillance culture and isolation
facilities are lacking. Finally, the increasing consumption of
antibiotics with activity against MRSA throughout the study
period might have constituted a confounding factor by decreasing
the nosocomial incidence of MRSA. However, since other broad
spectrum antibiotics which had selective pressure on MRSA also
increased, the stepwise decrease in the incidence of MRSA from
phase 1 to 3 were likely related to the infection control
interventions applied in phases 2 and 3 in our resource limited
setting, though this potential confounding factor should be further
evaluated in future studies.
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